LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

Accueil・Liste d'Actions・Waters Corp

Waters Corp

Fermé

SecteurSoins de santé

376.89 -0.73

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

374.63

Max

383.85

Chiffres clés
By Trading Economics
Revenu	-297M -72M
Ventes	335M 1.3B
P/E Moyenne du Secteur	48.112 49.888
BPA	2.7
Marge bénéficiaire	-5.683
Employés	16,000
EBITDA	-219M 106M

Recommandations
By TipRanks
Recommandations	Achat
Prévisions sur 12 Mois	+2.4% upside

Dividendes
By Dow Jones
Prochains Résultats	3 août 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	7.5B 37B
Ouverture précédente	377.62
Clôture précédente	376.89

Sentiment de l'Actualité

By Acuity

29%

71%

67 / 344 Classement par Healthcare

Waters Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

14 juil. 2025, 14:26 UTC

Acquisitions, Fusions, Rachats

Becton Dickinson Biosciences & Diagnostics Unit to Merge With Waters Corp. in $17.5 Billion Deal -- 2nd Update

14 juil. 2025, 11:08 UTC

Acquisitions, Fusions, Rachats

Becton Dickinson Unit to Combine With Waters Corp. in $17.5 Billion Deal -- Update

15 juil. 2025, 18:32 UTC

Acquisitions, Fusions, Rachats

Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks -- Analysis

15 juil. 2025, 18:31 UTC

Acquisitions, Fusions, Rachats

Waters Deal for Becton Unit Pairs Near-Term Risks With Possible Long-Term Rewards, Analysts Say

14 juil. 2025, 16:53 UTC

Actions en Tendance

Stocks to Watch Monday: Kenvue, Tesla, Synopsys, Robinhood -- WSJ

14 juil. 2025, 16:12 UTC

Market Talk

Acquisitions, Fusions, Rachats

Waters Closer to Thermo Fisher, Danaher With Becton Dickinson Unit -- Market Talk

14 juil. 2025, 15:06 UTC

Acquisitions, Fusions, Rachats

Waters Stock Is Falling on Deal to Combine With Becton Dickinson Unit -- Barrons.com

14 juil. 2025, 14:11 UTC

Acquisitions, Fusions, Rachats

Becton Dickinson Biosciences & Diagnostics Unit to Merge With Waters Corp. in $17.5B Deal -- 2nd Update

14 juil. 2025, 10:53 UTC

Acquisitions, Fusions, Rachats

Becton Dickinson Unit to Combine With Waters Corp. in $17.5B Deal -- Update

14 juil. 2025, 10:22 UTC

Acquisitions, Fusions, Rachats

Becton Dickinson Unit to Combine With Waters Corp. in $17.5B Deal

14 juil. 2025, 10:22 UTC

Acquisitions, Fusions, Rachats

Waters To Assume About $4 Billion Incremental Debt >WAT BDX

14 juil. 2025, 10:22 UTC

Acquisitions, Fusions, Rachats

Becton Dickinson to Get $4 Billion Cash Distribution Prior to Closing >WAT BDX

14 juil. 2025, 10:21 UTC

Acquisitions, Fusions, Rachats

Waters Holders to Own 60.8% of Combined Company, Becton Dickinson Holders to Own 39.2% >WAT BDX

14 juil. 2025, 10:20 UTC

Acquisitions, Fusions, Rachats

Waters, Becton Dickinson: Combined Company to Have About $9 Billion Revenue, $3.3 Billion Adjusted Ebitda >WAT

14 juil. 2025, 10:19 UTC

Acquisitions, Fusions, Rachats

Correct: Waters, Becton Dickinson See About $290 Million Revenue Synergies by Year Five >WAT BDX

14 juil. 2025, 10:19 UTC

Acquisitions, Fusions, Rachats

Waters, Becton Dickinson See About $345 Million Annualized Ebitda Synergies by 2030 >WAT BDX

14 juil. 2025, 10:18 UTC

Acquisitions, Fusions, Rachats

Waters, Becton Dickinson See About $290 Revenue Cost Synergies by Year Five >WAT BDX

14 juil. 2025, 10:18 UTC

Acquisitions, Fusions, Rachats

Waters, Becton Dickinson See About $200 Million Cost Synergies by Year Three >WAT BDX

14 juil. 2025, 10:17 UTC

Acquisitions, Fusions, Rachats

Waters: Becton Dickinson Deal Doubles Total Addressable Market to About $40 Billion >WAT

14 juil. 2025, 10:16 UTC

Acquisitions, Fusions, Rachats

Waters, Becton Dickinson Deal Structured as Reverse Morris Trust >WAT BDX

14 juil. 2025, 10:16 UTC

Acquisitions, Fusions, Rachats

Waters, Becton Dickinson Deal Valued at About $17.5 Billion >WAT BDX

14 juil. 2025, 10:15 UTC

Acquisitions, Fusions, Rachats

Waters to Combine With Becton Dickinson's Biosciences & Diagnostic Solutions Business >WAT BDX

14 juil. 2025, 10:15 UTC

Acquisitions, Fusions, Rachats

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine

Comparaison

Variation de prix

Waters Corp prévision

Objectif de Prix

By TipRanks

2.4% hausse

Prévisions sur 12 Mois

Moyen 388.88 USD 2.4%

Haut 440 USD

Bas 345 USD

Basé sur 17 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

17 ratings

Achat

Maintien

Vente

Basé sur 17 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Sentiment

By Acuity

67 / 344Classement par Soins de santé

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Waters Corp

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.